Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus-Reference-Cited by-同舟云学术

Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus

Published:2003-10 Issue:10 Volume:44 Page:2006-2014
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Kujiraoka Takeshi,Iwasaki Tadao,Ishihara Mitsuaki,Ito Mayumi,Nagano Makoto,Kawaguchi Akito,Takahashi Sadao,Ishi Jun,Tsuji Masahiro,Egashira Tohru,Stepanova Irina P.,Miller Norman E.,Hattori Hiroaki

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference39 articles.

1. Human plasma platelet-activating factor acetylhydrolase. Purification and properties;Stafforini;J. Biol. Chem.,1987

2. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor;Stafforini;J. Biol. Chem.,1987

3. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase;Stafforini;J. Clin. Invest.,1996

4. Mammalian platelet-activating factor acetylhydrolases;Stafforini;Biochim. Biophys. Acta.,1996

5. Platelet-activating factor acetylhydrolases;Stafforini;J. Biol. Chem.,1997

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of platelet-activating factor acetylhydrolase on the inflammatory and apoptotic processes in atherosclerosis;Phospholipases in Physiology and Pathology;2023

2. Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications;Journal of Clinical Medicine;2021-05-21

3. The Beneficial Effects of Alpha Lipoic Acid Supplementation on Lp-PLA2 Mass and Its Distribution between HDL and apoB-Containing Lipoproteins in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial;Oxidative Medicine and Cellular Longevity;2020-03-10

4. Evaluation of lipoprotein‐associated phospholipase A2 as a marker for renal microvasculopathy in adolescents with Type 1 diabetes;Diabetic Medicine;2019-08-05

5. Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes;Lipids in Health and Disease;2018-05-08